InhaleRx Limited (AU:IRX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InhaleRx Limited has announced the resignation of Dr. Andrew Saich and the appointment of Dr. Ronald Wise as a new director, effective immediately. Dr. Wise’s extensive experience in scientific and drug development sectors will support the company’s growth in developing inhaled drug-device products for pain management and mental health. This leadership change aligns with InhaleRx’s strategy to pursue significant economic opportunities by advancing its innovative treatments for conditions like Breakthrough Cancer Pain and Panic Disorder.
For further insights into AU:IRX stock, check out TipRanks’ Stock Analysis page.